A Phase I Trial to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer Vaccine, Adjuvanted
Clinical trial NCT03547245 · COMPLETED
Trial details
- NCT number
- NCT03547245
- Sponsor
- International AIDS Vaccine Initiative
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-15
- Primary completion
- 2020-01-17
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.